Ginkgo Bioworks Holdings DNA
NYSE DNA
$10.73 +0.88 (+8.93%)
As of: Nov 3, 2026 · 3:59 PM EST

Ginkgo Bioworks Holdings (DNA) Work In Process (2021)

Updated

Ginkgo Bioworks Holdings (DNA) reported Work In Process of $50,000 for Q4 2021, down 69.3% from the prior quarter.

Analysis

Ginkgo Bioworks Holdings (DNA) Work In Process (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.58 Bn 33.96 Bn 1.50 Bn
2 Medpace Holdings 18.13 Bn 15.77 Bn 223.89 Mn
3 Charles River Laboratories International 16.15 Bn 15.39 Bn 363.37 Mn
4 Icon 15.71 Bn 12.48 Bn 491.83 Mn
5 Fortrea Holdings 1.93 Bn 1.22 Bn 139.50 Mn
6 Ginkgo Bioworks Holdings 627.55 Mn -134.53 Mn 18.44 Mn
7 Evotec SE 540.45 Mn -1.07 Bn -
8 Champions Oncology 68.48 Mn 44.13 Mn 7.70 Mn
9 MindWalk Holdings 51.38 Mn 15.04 Mn 1.61 Mn
10 Natural Alternatives International 6.45 Mn -21.63 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 50,000.00
Sep 30, 2021 163,000.00
API Access

Ginkgo Bioworks Holdings Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=DNA&period=max&api_key=YOUR_API_KEY